SCHEDULE 13G

Avalo Therapeutics, Inc.

Common Stock, par value $0.001 per share · CUSIP: 05338F306

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Balyasny Asset Management L.P.

  Shares: 817,436 · Class: 6.22%

• BAM GP LLC

  Shares: 817,436 · Class: 6.22%

• Balyasny Asset Management Holdings LP

  Shares: 817,436 · Class: 6.22%

• Dames GP LLC

  Shares: 817,436 · Class: 6.22%

• Dmitry Balyasny

  Shares: 817,436 · Class: 6.22%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.